BM-573

CC1=CC=C(NC2=CC=C(C=C2S(=O)(=O)NC(=O)NC(C)(C)C)[N+]([O-])=O)C=C1

InChIKey=SILRUCMXYIKULW-UHFFFAOYSA-N

InChI=1S/C18H22N4O5S/c1-12-5-7-13(8-6-12)19-15-10-9-14(22(24)25)11-16(15)28(26,27)21-17(23)20-18(2,3)4/h5-11,19H,1-4H3,(H2,20,21,23)

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

PubMed

Title	Date	PubMed
Pharmacological characterization of N-tert-butyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea (BM-573), a novel thromboxane A2 receptor antagonist and thromboxane synthase inhibitor in a rat model of arterial thrombosis and its effects on bleeding time.	2004-05	14742735

Patents

Substance Class	Chemical Created by `admin` on `Mon Mar 31 23:38:30 GMT 2025` Edited by `admin` on `Mon Mar 31 23:38:30 GMT 2025`
Record UNII	8E9L957C3G
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

BM-573

Common Name

English

BENZENESULFONAMIDE, N-(((1,1-DIMETHYLETHYL)AMINO)CARBONYL)-2-((4-METHYLPHENYL)AMINO)-5-NITRO-

Preferred Name

English

Code System Code Type Description

EPA CompTox

DTXSID301121600

Created by admin on Mon Mar 31 23:38:30 GMT 2025 , Edited by admin on Mon Mar 31 23:38:30 GMT 2025

PRIMARY

FDA UNII

8E9L957C3G

Created by admin on Mon Mar 31 23:38:30 GMT 2025 , Edited by admin on Mon Mar 31 23:38:30 GMT 2025

PRIMARY

CAS

284464-83-1

Created by admin on Mon Mar 31 23:38:30 GMT 2025 , Edited by admin on Mon Mar 31 23:38:30 GMT 2025

PRIMARY

PUBCHEM

5312142

Created by admin on Mon Mar 31 23:38:30 GMT 2025 , Edited by admin on Mon Mar 31 23:38:30 GMT 2025

PRIMARY

Related Record Type Details


					8E9L957C3G

BM-573

ACTIVE MOIETY